Arcutis Biotherapeutics Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Arcutis Biotherapeutics Inc. | ARQT - NASDAQ |
$15.00-$17.00 | $17.00 | $23.05 | 9.6 million | 1/31/2020 |
| Goldman Sachs, Cowen, Guggenheim Securities | ||||||
Co-Manager(s): Cantor | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-01-06 Terms Added 2020-01-21 | ||||||
Arcutis Biotherapeutics Inc. Quote & Chart - Click for current quote - ARQT
IPO Boutique aggregates information on public companies and private companies, such as "ARQT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Arcutis Biotherapeutics Inc. (adapted from Arcutis Biotherapeutics Inc. prospectus):
They are a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ARQT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.